Skip to content
Meet your potential

Neuro Infiny

  • OUR SERVICES
  • YOUR FEEDBACK
  • E SHOP
Neuro Infiny

Tag: headache

A 23-Year-Old With Blindness After a Fall She Can’t Remember

A 23-Year-Old With Blindness After a Fall She Can’t Remember

markJanuary 9, 2020Leave a comment
Background A 23-year-old woman is brought to the emergency department by her concerned mother after experiencing an apparent fall. The...
Read More
The Headache Most Often Misdiagnosed

The Headache Most Often Misdiagnosed

markJanuary 9, 2020January 9, 2020Leave a comment
A 29-year-old woman presents for evaluation of headaches. She reports that they have grown increasingly frequent over the past 12...
Read More
Light and Sound Sensitivity in Migraine Explained?

Light and Sound Sensitivity in Migraine Explained?

markJanuary 9, 2020January 9, 2020Leave a comment
Researchers have correlated light and sound sensitivity experienced by some patients with migraine who have heightened connectivity within primary sensory...
Read More
Acute Migraine Drug Hits Co-primary Endpoints in Phase 3 Trial

Acute Migraine Drug Hits Co-primary Endpoints in Phase 3 Trial

markJanuary 9, 2020Leave a comment
January 03, 2020 Topline results from the phase 3 MOMENTUM trial show the experimental migraine drug AXS-07 (Axsome Therapeutics) met both of...
Read More
Chronic paroxyzmal Hemicrania part 2.nd

Chronic paroxyzmal Hemicrania part 2.nd

markJanuary 6, 2020January 6, 20201 Comment
Epidemiology Occurrence in the United States CPH is a rare syndrome, but the number of diagnosed cases is increasing. The...
Read More
Chronic Paroxysmal Hemicrania part 1.st

Chronic Paroxysmal Hemicrania part 1.st

markJanuary 6, 2020January 6, 2020Leave a comment
Background Chronic paroxysmal hemicrania (CPH), also known as Sjaastad syndrome, was first described in 1974, by Sjaastad and Dale. In...
Read More
FDA OKs Ubrogepant (Ubrelvy) for Acute Migraine Treatment

FDA OKs Ubrogepant (Ubrelvy) for Acute Migraine Treatment

markDecember 30, 2019December 30, 2019Leave a comment
The US Food and Drug Administration (FDA) has approved ubrogepant (Ubrelvy, Allergan) for the acute treatment of migraine with or...
Read More

Categories

ADHD Cranial nerves Dementia Demyelination disorders Depression Education management Epilepsy Examination Headache Huntington disease Migraine Movement disordes Multiple sclerosis Muscle disorders Neoplasia Neurobiology Neuromuscular disorders Neuropharmacology Neuropsychiatry News Pain Parkinson disease Rare diseases Sleep disorders Stroke Vertebropathy
https://www.youtube.com/watch?v=MkNeIUgNPQ8&list=PLzCxunOM5WFLNCSF0UEHZqFJJlmdeL71S
Neuro Infiny
Proudly powered by WordPress | Theme: refur by Crocoblock.
sponsored
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.